A detailed history of Wealthcare Advisory Partners LLC transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Wealthcare Advisory Partners LLC holds 241,000 shares of SENS stock, worth $204,850. This represents 0.0% of its overall portfolio holdings.

Number of Shares
241,000
Previous 253,100 4.78%
Holding current value
$204,850
Previous $88,000 42.05%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 15, 2025

SELL
$0.25 - $0.59 $3,025 - $7,139
-12,100 Reduced 4.78%
241,000 $125,000
Q2 2024

Aug 09, 2024

BUY
$0.37 - $0.52 $37 - $52
100 Added 0.04%
253,100 $101,000
Q1 2024

Apr 15, 2024

BUY
$0.5 - $0.73 $4,100 - $5,986
8,200 Added 3.35%
253,000 $134,000
Q4 2023

Feb 06, 2024

BUY
$0.48 - $0.7 $288 - $420
600 Added 0.25%
244,800 $139,000
Q3 2023

Oct 12, 2023

SELL
$0.5 - $1.05 $675 - $1,417
-1,350 Reduced 0.55%
244,200 $146,000
Q2 2023

Jul 17, 2023

BUY
$0.55 - $0.89 $19,250 - $31,150
35,000 Added 16.62%
245,550 $186,000
Q2 2022

Aug 15, 2022

BUY
$0.94 - $1.94 $54,238 - $111,938
57,700 Added 37.75%
210,550 $217,000
Q1 2022

Apr 15, 2022

BUY
$1.54 - $3.71 $35,420 - $85,330
23,000 Added 17.71%
152,850 $301,000
Q4 2021

Feb 11, 2022

BUY
$2.58 - $3.91 $78,948 - $119,646
30,600 Added 30.83%
129,850 $346,000
Q3 2021

Nov 15, 2021

BUY
$2.77 - $4.05 $110,523 - $161,595
39,900 Added 67.23%
99,250 $336,000
Q2 2021

Aug 16, 2021

BUY
$1.71 - $4.14 $27,103 - $65,619
15,850 Added 36.44%
59,350 $228,000
Q1 2021

Apr 30, 2021

BUY
$0.85 - $5.27 $36,975 - $229,244
43,500 New
43,500 $115,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $396M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Wealthcare Advisory Partners LLC Portfolio

Follow Wealthcare Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.